METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONISTS COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES
US Application 63/352,428
Filed on 2022-06-15
Filed on 2022-06-15
SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
US Application 63/290,409
Filed on 2021-12-16
Filed on 2021-12-16
CANNABINOID RECEPTOR MODULATING COMPOUNDS
US Application 63/319,642
Filed on 2022-03-14
Filed on 2022-03-14
Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds
US Application 63/265,225
Filed on 2021-12-10
Filed on 2021-12-10
Process / Methodology To Convert Ureas / Sulfonyl Ureas To Chalcogenide Ureas / Sulfonyl Ureas
US Application 63/189,375
Filed on 2021-05-17
Filed on 2021-05-17
Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
US Application 61/783,167
Filed on 2013-03-14
Filed on 2013-03-14
CANNABINOID RECEPTOR MEDIATING COMPOUNDS
US Application 62/171,179
Filed on 2015-06-04
Filed on 2015-06-04
Cannabinoid Receptor Mediating Compounds
US Application 61/991,333
Filed on 2014-05-09
Filed on 2014-05-09
GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS
US Application 61/839,239
Filed on 2013-06-25
Filed on 2013-06-25
CANNABINOID RECEPTOR MEDIATING COMPOUNDS
US Application 61/725,949
Filed on 2012-11-13
Filed on 2012-11-13